* Graphic:
OSLO, Dec 4 (Reuters) - Norway will use the three vaccines
developed by Moderna, AstraZeneca, Pfizer
and BioNTech in its first push to inoculate
its population against COVID-19, the country's health minister
said on Friday.
In the first quarter of 2021, Oslo expects to receive a
total of 2.5 million doses, covering 1.25 million people.
Norway's population is 5.4 million.
Non-EU Norway will get access to vaccines obtained by the
European Union thanks to Sweden, an EU member that will buy more
than it needs and sell them to Norway.
(Reporting by Gwladys Fouche; editing by Victoria Klesty)
Astrazeneca (AZN)
